SCHEMBL25622935

SCHEMBL25622935

CCOC(=O)CC(=O)C1CC=C(C)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.46
▸ TSHR P16473 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ MGAM O43451 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ SI P14410 1/20 0.41
▸ MGAM2 Q2M2H8 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ ALOX15 P16050 3/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ PKM P14618 1/20 0.35
▸ PTPN1 P18031 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ POLB P06746 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ NFKB1 P19838 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31601392 0.81 LMNA (0.51) LMNATSHRRAB9AALDH1A1NPC1
SCHEMBL2431486 0.81 LMNA (0.51) LMNATSHRRAB9AALDH1A1NPC1
SCHEMBL4740720 0.80 LMNA (0.55) LMNATSHRRAB9AALDH1A1NPC1
SCHEMBL4472607 0.80 LMNA (0.55) LMNATSHRRAB9AALDH1A1NPC1
SCHEMBL10831405 0.78 LMNA (0.51) LMNATSHRRAB9AALDH1A1NPC1
(-)-Limonene SCHEMBL1273506 0.76 LMNA (0.63) LMNATSHRRAB9AALDH1A1NPC1
SCHEMBL1014646 0.76 GAA (0.58) LMNARAB9AALDH1A1MGAMGAA
SCHEMBL15182066 0.75 SMN1; SMN2 (0.49) LMNATSHRRAB9AALDH1A1MGAM
SCHEMBL17036172 0.75 MGAM (0.44) LMNATSHRRAB9AALDH1A1MGAM
D-Limonene SCHEMBL8318907 0.75 LMNA (0.71) LMNATSHRRAB9AALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183186-A1 PYRIMIDINE CYCLOHEXENYL GLUCOCORTICOID RECEPTOR MODULATORS CORCEPT THERAPEUTICS INCORPORATED 2023-06-15 — — US disclosed
US-9671392-B2 Multisensor array for detection of analytes or mixtures thereof in gas or liquid phase DANMARKS TEKNISKE UNIVERSITET (DK) 2017-06-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183186-A1 PYRIMIDINE CYCLOHEXENYL GLUCOCORTICOID RECEPTOR MODULATORS NR3C1, NR3C2, MC2R LMNA 4762/4885TSHR 216/4885RAB9A 4630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback